Intelence (Janssen Products LP)


Welcome to the PulseAid listing for the Intelence drug offered from Janssen Products LP. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Products LP
NON-PROPRIETARY NAME: etravirine
SUBSTANCE NAME: ETRAVIRINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-01-18
END MARKETING DATE: 0000-00-00


Intelence HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIntelence from Janssen Products LP
LABELER NAME: Janssen Products LP
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2008-01-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59676-570_10c0b502-9857-436d-883f-602b1f684aca
PRODUCT NDC: 59676-570
APPLICATION NUMBER: NDA022187

Other ETRAVIRINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Products LPIntelence
Physicians Total Care, Inc.Intelence
State of Florida DOH Central PharmacyIntelence